Baxter's Commentary on M&A

May 13, 2016

1 Min Read
Does Medtech Have an Appetite for M&A?—Baxter

Baxter's Commentary on M&A

"We talk about M&A, and obviously M&A is opportunistic, but transformative M&A is not in the cards as we speak right now. So we're looking at strengthening our current core businesses, and by doing it, we're going to go into adjacencies . . .

As currency weakens in some countries in Latin America, offers an opportunity for potential acquisitions there at a reasonable price, with a good return on investment. . . 

We also will be very diligently looking for partnerships and acquisitions to supplement [the Integrated Pharmacy Solutions] business, because we think there's a great deal of opportunity for the company there as an adjacency."

José Almeida, Baxter chairman, president, and CEO, according to a Seeking Alpha transcript of the company's first quarter earnings call


Get inspired to innovate in medtech at the MD&M East Conference, June 14-16, in New York City. 


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like